跳至主要内容
临床试验/KCT0002292
KCT0002292已完成未知

Effects of multiple probiotics administration on obesity and obesity related metabolic indicators: a randomized, double-blind, placebo-controlled trial

Dongguk University Ilsan Oriental Hospital0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 60(Year)(—)
性别
All

入选标准

  • 1. BMI (body mass index) of over 25kg/m2, men and women aged between 20-60 years
  • 2. Participants who voluntarily decided to participate in this human clinical study and those who agreed to it.
  • 3. Participants who are reliable and willing to cooperate with this study.

排除标准

  • 1. patients who have lost or gain more than 10% of body weight within 3 months
  • 2. severe liver or renal dysfunction(ALT(Alanine Aminotransferase), AST(Aspartate Aminotransferase) = 2.5 fold upper limit of normal) (Cr > 2.0mg/dl)
  • 3. patients with any condition that can affect weight gain such as hypothyroidism, cushing syndrome
  • 4. heart disease(heart failure, angina pectoris, myocardial infarction)
  • 5. cancer or lung disease
  • 6. patients who are diagnosed with cholelithiasis
  • 7. Narrow angle glaucoma
  • 8. past history of stroke, transient ischemic heart disease
  • 9. Patients who have psychiatric disorder such as delirium, confusion or those who have psychiatric diseases that may affect the performance and evaluation of human clinical study.
  • 10. patients who underwent surgeries for weight reduction(gastroplastia)
  • 11. eating disorder such as anorexia nervosa and bulimia nervosa
  • 12. patients who have taken anorexiants, relievers(without prescription), oral steroid, thyroid hormone, amphetamine, cyproheptadine, phenothiazine, or any other medication within 3 months that can affect absorption, metabolism, excretion which can affect on weight.
  • 13. who are on narcotics and neuropsychological drugs for weight reduction
  • 14. patients who underwent anatomical change such as incision which makes it difficult to conduct physical measurements
  • 15. pregnant women, women planning a pregnancy and those who receive hormone or SSRI (Selective Serotonin Reuptake Inhibitors) medication
  • 16. patients who had received antiboitics or probiotics within 1 month
  • 17. patients who have taken other medications provided by clinical trial within a month
  • 18. patients who have given up on smoking within past 3 months but who have irregular smoking habit
  • 19. In addition, based on the researcher's evaluation, participants who is not appropriate for participating in this human clinical study

研究者

发起方
Dongguk University Ilsan Oriental Hospital

相似试验